NOROVIRUS-IMPFSTOFF-FORMULIERUNGEN

European patent · EP2601970 · Deleted

Register entry

Publication number
EP2601970
Application number
EP13157573
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Sep 28, 2007
Published
Jun 12, 2013
Granted
Oct 26, 2016
Deleted
Sep 14, 2022
Reason
Revoked in opposition
IPC classes
A61K 39/42 (2006.01)
A61K 39/12 (2006.01)
Priority
US 847912 P 29.09.2006
US 973392 P 18.09.2007
Divided from
EP07853688
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 14, 2022

    Change

    Published in Swissreg on 14.09.2022

  2. Sep 23, 2021

    Change

    Published in Swissreg on 23.09.2021

  3. Sep 23, 2021

    Change

    Published in Swissreg on 23.09.2021

  4. Oct 26, 2016

    Granted

    Published in Swissreg on 26.10.2016

Parties

Holder

Takeda Vaccines, Inc.

One Takeda Parkway, Deerfield, IL 60015, US

Inventor

Richardson, Charles

Deerfield, IL 60015, US

Vedvick, Thomas S.

Deerfield, IL 60015, US

Foubert, Thomas R.

Deerfield, IL 60015, US

Tino, William T.

Deerfield, IL 60015, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.